303 related articles for article (PubMed ID: 20030437)
1. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
Davies AJ; Kalson NS; Stokes S; Earl MD; Whitehead AG; Frost H; Tyrell-Marsh I; Naylor J
Wilderness Environ Med; 2009; 20(4):311-7. PubMed ID: 20030437
[TBL] [Abstract][Full Text] [Related]
2. Mt. Whitney: determinants of summit success and acute mountain sickness.
Wagner DR; D'Zatko K; Tatsugawa K; Murray K; Parker D; Streeper T; Willard K
Med Sci Sports Exerc; 2008 Oct; 40(10):1820-7. PubMed ID: 18799993
[TBL] [Abstract][Full Text] [Related]
3. Risk Determinants of Acute Mountain Sickness and Summit Success on a 6-Day Ascent of Mount Kilimanjaro (5895 m).
Lawrence JS; Reid SA
Wilderness Environ Med; 2016 Mar; 27(1):78-84. PubMed ID: 26948557
[TBL] [Abstract][Full Text] [Related]
4. Twice-daily assessment of trekkers on Kilimanjaro's Machame route to evaluate the incidence and time-course of acute mountain sickness.
Meyer J
High Alt Med Biol; 2012 Dec; 13(4):281-4. PubMed ID: 23270446
[TBL] [Abstract][Full Text] [Related]
5. Acute mountain sickness in Jade Mountain climbers of Taiwan.
Kao WF; Kuo CC; Hsu TF; Chang H; Sung YY; Yen DH; Wu JK; Lee CH
Aviat Space Environ Med; 2002 Apr; 73(4):359-62. PubMed ID: 11952056
[TBL] [Abstract][Full Text] [Related]
6. Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya.
Vardy J; Vardy J; Judge K
Aviat Space Environ Med; 2006 Jul; 77(7):742-4. PubMed ID: 16856361
[TBL] [Abstract][Full Text] [Related]
7. Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas.
Basnyat B; Lemaster J; Litch JA
Aviat Space Environ Med; 1999 Sep; 70(9):867-73. PubMed ID: 10503751
[TBL] [Abstract][Full Text] [Related]
8. Change in oxygen saturation does not predict acute mountain sickness on Jade Mountain.
Chen HC; Lin WL; Wu JY; Wang SH; Chiu TF; Weng YM; Hsu TY; Wu MH
Wilderness Environ Med; 2012 Jun; 23(2):122-7. PubMed ID: 22656657
[TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
[TBL] [Abstract][Full Text] [Related]
10. Different duration of high-altitude pre-exposure associated with the incidence of acute mountain sickness on Jade Mountain.
Weng YM; Chiu YH; Lynn JJ; Li WC; Wang SH; Kao WF; Hsu TY; Chiu TF; Lin YJ; Chan CW
Am J Emerg Med; 2013 Jul; 31(7):1113-7. PubMed ID: 23688567
[TBL] [Abstract][Full Text] [Related]
11. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
[TBL] [Abstract][Full Text] [Related]
12. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro.
Jackson SJ; Varley J; Sellers C; Josephs K; Codrington L; Duke G; Njelekela MA; Drummond G; Sutherland AI; Thompson AA; Baillie JK
High Alt Med Biol; 2010; 11(3):217-22. PubMed ID: 20919888
[TBL] [Abstract][Full Text] [Related]
13. Oximetry fails to predict acute mountain sickness or summit success during a rapid ascent to 5640 meters.
Wagner DR; Knott JR; Fry JP
Wilderness Environ Med; 2012 Jun; 23(2):114-21. PubMed ID: 22656656
[TBL] [Abstract][Full Text] [Related]
14. Risk determinants of acute mountain sickness in trekkers in the Nepali Himalaya: a 24-year follow-up.
McDevitt M; McIntosh SE; Rodway G; Peelay J; Adams DL; Kayser B
Wilderness Environ Med; 2014 Jun; 25(2):152-9. PubMed ID: 24864065
[TBL] [Abstract][Full Text] [Related]
15. Can knowledge protect against acute mountain sickness?
Vardy J; Vardy J; Judge K
J Public Health (Oxf); 2005 Dec; 27(4):366-70. PubMed ID: 16234261
[TBL] [Abstract][Full Text] [Related]
16. Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up.
Gaillard S; Dellasanta P; Loutan L; Kayser B
High Alt Med Biol; 2004; 5(4):410-9. PubMed ID: 15671630
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal.
Newcomb L; Sherpa C; Nickol A; Windsor J
Wilderness Environ Med; 2011 Sep; 22(3):197-201. PubMed ID: 21962045
[TBL] [Abstract][Full Text] [Related]
18. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
[TBL] [Abstract][Full Text] [Related]
19. Incidence of acute mountain sickness in UK Military Personnel on Mount Kenya.
Hazlerigg A; Woods DR; Mellor AJ
J R Army Med Corps; 2016 Dec; 162(6):465-469. PubMed ID: 26604255
[TBL] [Abstract][Full Text] [Related]
20. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
Bernhard WN; Schalick LM; Delaney PA; Bernhard TM; Barnas GM
Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
